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Summary: The determination of creatinine by HPLC was performed by direct injection of serum onto the
column, and after ultrafiltration of the sample, and the results were compared. A modified weak cation
exchange column was used for HPLC. This eliminates the protein displacement effect and the Gibbs-Donnan
effect, thus permitting a rapid direct analysis. Three of the four ultrafiltration methods gave almost identical
analytical results. Regression analyses of the results from direct serum injection versus ultrafiltration showed
a bias of 5% on the slope y = 1.050 · χρι1Γβ serum + 1.856, which was in our view solely due to the volume
displacement effect of the proteins; correction of each data point by a protein-dependent correction factor
resulted in an almost perfect regression line.
Introduction
The value of high-performance chromatography
(HPLC) as an analytical method for the determination
of creatinine in serum, depends on its design and
application. Several publications report the use of this
technique as a (candidate) reference method, or a
selected method (1 — 5).
In others, HPLC is simply used to measure creatinine
concentrations in serum or urine (6 — 10).
In the latter case, a rapid throughput and thus a
minimal number of experimental steps is desired. In
a reference technique, however, time is not as impor-
tant as precision and accuracy. In both applications,
it is necessary to remove proteins, either by acid
precipitation or by ultrafiltration (12, 13) and irre-
spective of the chosen technique, the volume displace-
ment effect of the removed proteins must be taken
into account in the interpretation of the results.
The technique as described by us (5) is an easy-to-use
and accurate back-up system for the comparison of
large sets of creatinine samples. Because of the work-
load we felt the need to improve the absolute speed
of our HPLC system (6 samples/hour).
We therefore considered two options for decreasing
the operation time by a factor 2 or 3:
a. use of a shorter column
b. increased flow.
In addition, we wished to investigate the problem of
accucary by studying the ultrafiltration step in more
detail. We therefore compared the ultrafiltration tech-
nique with a HPLC method developed by us, which
does not involve deproteinization, and we also com-
pared different ultrafiltration units.
Materials and Methods
Materials
Reagents
All chemicals were essentially the same as in our previous study
(5).
The serum samples were stored for up to one month at — 80 °C
until further use.
Kontrollogen L and Kontrollogen LP control sera from Beh-
ringwerke A. G., Marburg, Germany, together with three ref-
erence sera (A, B, C) from the Deutsche Gesellschaft f r Kli-
nische Chemie (Zentrale Referenzinstitution) were used as con-
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trol material. In all sera, the creatinine was determined by
isotope dilution-mass spectrometry and by a validated reference
method.
The tested ultrafiltration units were:
a) Centrifree Micropartition System, Amicon Division, W. R.
Grace & Co., Beverly (U. S. A.).
b) Centrisart-I, Sartorius, G ttingen (Germany).
c) Ultracent, Βίο-Rad Laboratories, Richmond (U. S. A.).
d) Ultrafree-MC, Millipore Product Division, Bedford
(U.S.A.).
Methods
Ultrafiltration
The Centrifree Micropartition System needs a fixed-angle rotor
(JA-21 Beckman, 20 min at 1000 g) to provide an ultrafiltrate.
The Ultrafree system was used in an Eppendorf (5414) centri-
fuge (60 min at 10000g) with a fixed-angle rotor.
The other two systems, Ultracent and Centrisart-I can produce
an ultrafiltrate in a centrifuge with a swing-head rotor (40 min
at 2900 g).
All four units carried a semipermeable membrane (cut-off
M r« 10000).
Because of the volume displacement effect of the proteins, we
used a protein-dependent factor to adjust for this change in
volume according to Weast (14).
Sample preparation
A serum sample (100-300 μΐ) was centrifuged for 20-40
minutes and 10 μΐ ultraflltrate was directly injected into the
HPLC system.
Direct injection of 5 μΐ of a serum sample onto the same system
needs no preparation, except for turbid samples, which can be
clarified with a Seraclear® filter (Bayer-Technicon, Tarrytown,
U. S. A.). Sera were diluted with a Microlab M dilutor (Ham-
ilton, Switzerland); 1000 μΐ serum were diluted with 1000, 2000,
3000 or 4000 μΐ NaCl, 154 mmol/1.
Total protein determination
We used the Technicon Chem-1 system for the total protein
estimations (Biuret procedure).
High performance liquid chromatography (HPLC)
The HPLC system described in 1. c. (5) was used. We used the
same weak cation-exchange column, with two appropriate mod-
ifications: the pore size was changed from 7 to 11 nm, and the
column dimensions were 100 χ 4.6 mm I. D. and 50 χ 4.6 mm
I.D.
Flow rates were 1.0 ml/min for the 150 mm column, and 1.5
ml/min for the 100 mm and the 50 mm columns.
Statistical analysis
Results were compared by regression analyses according to
Passing & Bablok (15). Significance of differences between
medians of series of assay determinations was calculated with
the Wilcoxon test for paired results; ρ < 0.01 was taken as
significant.
Results
To evaluate the shorter columns we used a serum
bank of 36 non-haemolytic, non-icteric and non-li-
paemic sera with creatinine concentrations ranging
from 40 to 1250 μηιοΐ/ΐ; these samples were also
analysed with our original method.
The use of a slightly larger pore size for the stationary
phase improved the peak shape considerably. Tailing
peaks (fig. 1) were abolished, thereby improving the
resolution of the creatinine peak. In combination with
the increased flow-rate of 1.5 ml/min, the retention-
time of creatinine decreased from 5.6 min to 4.2 min
on the 100 mm and to 2.8 min on the 50 mm column.
The 50 mm column was therefore chosen, because
only with this column were we able to increase the
total number of analyses from 6 to 12 per hour.
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Fig. 1. The same ultrafiltrate analysed on the 150 mm colum
(a), and on the 50 mm column (b), attenuation is 32
(25).
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Fig. 2. The creatinine concentrations of 36 ultrafiltrates ana-
lysed on the 150 mm column (x-axis) and on the 50 mm
column (y-axis), showing a perfect correlation.
Υ = 1.006X-3.648; r = 0.99992
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Tab. 1. Method comparison (y = ax + b) between the Centrifree MPS unit (x) and three other ultrafiltration units (y).
Filtration
Unit
Ultracent3
Centrisartb
Ultrafreec
Ultrafreed
a
0.991 (0.987-0.994)
0.994 (0.988-0.998)
1.177 (1.150-1.210)
1.002 (0.953-1.024)
b
-0.017 (-0.486-0.941)
+ 0.171 (-0.762-1.103)
-1.075 (-5.178-3.751)
-0.956 (-3.154-5.326)
n
36
36
36
10
r
0.99996
0.99987
0.99631
0.99967
Median χ
imol/1)
237.4
237.4
237.4
90.8
Median y
Oimol/1)
235.0
237.4
270.1
87.3
a
 Ultracent significantly different from Centrifree (p < 0.01).
b
 Centrisart not significantly different from Centrifree.
d
 Ultrafree used in a cold room (4 °C), not significantly different from Centrifree.
a
"
d
 Wilcoxon signed ranks test.
Note: data between brackets are the 95% confidence limits.
The results of the ultrafiltrates analysed on the 150
mm and the 50 mm column are plotted in figure 2.
The correlation study showed an excellent regression
line (ysomm = 1.006x150mm - 3.648), and 95% confi-
dence interval (r = 0.99992), with 1.001 - 1.010 for
the slope and -4.855 2.013 for the intercept.
Median χ = 237.4 μηοΐ/ΐ, median y = 236.2 μιηοΐ/l.
In a preliminary study we applied the Centrifree sys-
tem, which suffers from the one drawback that it
requires a fixed angle rotor centrifuge. We were there-
fore also interested in equivalent systems which only
need a laboratory centrifuge with a swing rotor.
We used the 50 mm column to analyse the ultrafil-
trates of the same 36 sera, and compared the results
with those from the three other systems.
The Ultracent- and the Centrisart units gave nearly
identical creatinine results, whereas the slope of the
results from the Ultrafree unit showed a positive bias;
we believe that this difference was due to the extremely
long centrifugation time (60 — 80 min) at room tem-
perature. When we repeated the experiment, with a
subset of 10 serum samples in a cold room (4 °C, 60
min), the results from the Ultrafree unit were identical
to those from the Centrifree unit.
Statistics are summarized in table 1.
The differences between the tested ultrafiltration
units, when properly used, are negligibly small, but
on basis of the Wilcoxon signed ranks test only the
Centrisart unit was not significantly different from
the Centrifree filter.
The remaining question was how to study the vali-
dation of the ultrafiltration step irrespective of the
column used. Ultrafiltration of serum is used to pro-
tect the analytical column, and it results in a slight
rise of the creatinine concentration, due to the protein
displacement effect. To compensate for this effect we
used a protein (dependent) factor. However, to meas-
ure the true creatinine concentration in serum, one
has to inject the pure serum and consider this to be
the golden standard. The correlation study of the 100
mm and the 150 mm column showed again an excel-
lent regression line: yioomm = 1.005x150inm — 3.558,
r = 0.99944 (95% confidence interval), with 0.996
- 1.016 for the slope and -4.397 0.742 for the
intercept. Median χ = 237.4 μηιοΙ/1, median
y = 238.7 μιηοΐ/ΐ.
Therefore we used our experimental 100 mm column
to compare a series of ultrafiltrates and pure sera,
and we investigated whether the application of pure
serum could be used to validate the protein correction
factor.
The same 36 sera, together with 3 control sera, were
analysed before and after ultrafiltration.
The Centrifree units were used to produce the ultra-
filtrates.
The only drawback was the rapid deterioration of the
column, which became very noticeable after about 70
injections. Two typical chromatograms are shown in
figure 3. Nevertheless, we were able to use the column
again after a rigorous clean-up (24 hours of dilute
phosphoric acid pH 3 and 8 hours 100% methanol).
The creatinine results correlate almost perfectly be-
tween pure serum and the ultrafiltrates, with a bias
on the slope of only 1.050.
Correction with a protein-dependent factor (tab. 2),
or even with a fixed protein factor (0.9465) removed
all significant differences between the pure sera and
the ultrafiltrates, confirming that the difference be-
tween ultrafiltrates and the native sera is mainly due
to the protein displacement effect.
Because of the minor difference between the two
calculation techniques we think that for routine anal-
yses the use of a fixed protein factor is a valid option.
The regression results are shown in table 3.
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Fig. 3. A chromatogram of pure serum on a new column (a), and a chromatogram of pure serum after ± 70 injections (b),
analysed on the 100 mm column; attenuation is 8 (23), injection volume 5 μΐ. The deterioration of the column can be seen
in the void peak, and in a slight decrease in retention time.
Tab. 2. The correction of the creatinine concentration, on the basis of the total protein content of 36 sera, as described by Weast
(14).
Sample
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Protein
(g/1)
58
52
74
69
68
67
80
46
63
68
53
63
55
72
71
71
65
70
55
66
63
43
71
73
81
68
73
59
70
66
70
60
55
47
63
67
Factor1
0.9566
0.9606
0.9444
0.9485
0.9485
0.9495
0.9404
0.9657
0.9525
0.9485
0.9606
0.9525
0.9586
0.9465
0.9465
0.9465
0.9505
0.9465
0.9586
0.9505
0.9525
0.9677
0.9465
0.9444
0.9394
0.9485
0.9444
0.9545
0.9470
0.9505
0.9470
0.9545
0.9586
0.9646
0.9525
0.9495
Filtrate
(μηιοΙ/1)
43.7
53.7
70.8
83.3
99.6
139.6
171.0
194.6
231.8
284.9
380.0
418.3
541.2
647.7
766.5
842.5
946.9
1119.4
1303.1
79.2
63.0
53.0
55.7
108.6
166.8
105.6
81.2
220.1
268.4
459.7
842.0
882.7
1283.6
693.3
964.0
555.4
Filtrate2
Gimol/1)
41.8
51.0
66.9
79.0
94.4
132.5
160.8
188.0
220.8
270.2
365.0
398.5
518.8
613.0
725.4
797.4
900.0
1059.4
1249.1
75.3
60.0
51.3
52.7
102.6
156.7
100.1
76.7
210.1
254.2
436.9
796.9
842.6
1230.4
668.8
918.2
527.3
Direct3
Gimol/1)
39.1
50.2
66.7
77.8
95.8
130.1
162.0
185.4
222.1
270.3
359.7
400.2
520.5
615.1
729.4
804.6
892.1
1054.8
1223.3
73.5
57.4
50.4
49.2
98.2
154.5
98.9
73.4
206.8
251.6
432.7
772.2
856.9
1219.4
671.6
929.6
525.2
1
 Factor as determined on basis of the protein content.
2
 Filtrate after correction with a protein-dependent factor.
3
 Injection of 5 μΐ serum direct onto the HPLC column.
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Tab. 3. Method comparison (y = ax + b) of 36 sera analysed as pure serum (x) and as ultrafiltr te (y).
Ultrafiltrate3
Ultrafiltrateb
Ultrafiltrate0
a
1.050 (0.178-3.119)
0.993 (0.986-1.000)
0.998 (0.991-1.006)
b
1.856 (1.043-1.057)
1.755 (0.168-2.949)
2.201 (0.643-3.315)
n
36
36
36
r
0.99979
0.99979
0.99988
Median χ
(μηιοΐ/l)
236.9
236.9
236.9
Median y
(μπιοΐ/ΐ)
250.1
236.5
237.4
a
 Ultrafiltrate not corrected, y significantly different from χ (p < 0.01).
b
 Ultrafiltrates corrected with a fixed factor of 0.9456, y not significantly different from x.
c
 Ultrafiltrates corrected with a protein-dependent factor, y not significantly different from x.
a
~
c
 Wilcoxon signed ranks test.
Note: data between brackets are the 95% confidence limits.
Tab. 4. Accuracy of direct injection compared with that of the
reference method and injection after ultrafiltration.
Pool
Pure sera
A
B
C
Ultrafiltrate
A
B
C
Reference
value3
(μηιοΐ/ΐ)
155
221
593
155
221
593
Meanb
(μπιοΐ/ΐ)
152.9
214.5
585.9
152.5
213.5
588.4
SD
(μπιοΐ/l)
2.4
1.7
7.9
1.3
2.2
3.9
CV
(%)
1.5
0.8
1.4
0.9
1.0
0.7
Ά
 Values determined by the reference method used
'Deutsche Gesellschaft f r Klinische Chemie'.
h
 Mean values are calculated from n = 5.
by the
The accuracy of the modified procedure was investi-
gated with 3 reference sera, and the results are sum-
marized in table 4.
As the 100 mm column performed so well, we won-
dered if the costs of an analytical column could coun-
terbalance the costs of the ultrafiltration units, if we
used diluted sera to delay column deterioration.
Five dilutions (1 ml + 0 ml, 1 ml + ..., 1 ml + 4 ml)
were made of 5 normal serum pools. The resulting
creatinine concentrations ranged from 79 to 456
μπιοΐ/ΐ.
We checked the precision of the dilutor by diluting a
serum sample (1 ml H- 2 ml) 9 times and found a mean
of 127.5 μηιοΐ/ΐ, a SD of 0.54 μηιοΐ/ΐ and a CV of
0.4%.
These results are within the normal within-run pre-
cision of this method (Kontrollogen L mean =121
μιηοΐ/ΐ, SD = 1.7 μιηοΐ/l, CV 1.4%).
Although the column performed for slightly longer
with a reasonable selectivity (99 samples instead of
72), the experiments were not convincing. After 309
injections the column was unfortunately destroyed.
Discussion
The use of a 50 mm column in combination with the
increased flow of 1.5 ml/min made it possible to cut
down the overall run time for one creatinine deter-
mination from approximately 9 min to 4.5 min. This
means that in an "emergency", the method is now
more suited for problematic routine samples.
Using the short column, the time for incubation,
calibration with 3 standards and the measurement of
the sample and a control sample is now less than 1
hour.
The choice of the ultrafiltration unit is arbitrary. On
basis of the Wilcoxon test, we found no difference
between the Centrifree and the Centrisart filter. We
therefore prefer the Centrisart unit because it pro-
duces an Ultrafiltrate in a simple laboratory centri-
fuge.
The price of an ultrafiltration unit is high (± Dfl 5.00
per unit). An HPLC column is also expensive. The
break-even point of the HPLC column is about 400
injections, but we did not reach that point. After
approximately 300 injections and 3 clean-ups, the
peak shape was such that we decided to replace the
column.
Nevertheless the use of direct serum injection is pos-
sible, and it is a very simple and reliable way to
evaluate reference and control sera.
In conclusion, for the determination of creatinine,
HPLC with a modified weak cation exchanger and a
column length of 50 mm or even less, is faster than
the modification we described earlier, and peak-shape
is improved considerably. Application of a fixed pro-
tein factor means that it is also a simple and suffi-
ciently accurate back-up system for patient sera. Ul-
trafiltration is necessary to obtain a clean HPLC
sample. When ultrafiltered samples are used, the col-
umn has an almost infinite lifetime (our first 150 mm
column is still in use after ± 4000 injections.
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Direct serum injection circumvents the use of a pro-
tein correction factor and is in our view an elegant
way to upgrade our method to a reference method
for the evaluation of reference material.
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